solifenacin succinate has been researched along with Urinary Bladder, Neurogenic in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, KW; Li, P; Wang, G; Xu, R; Yang, TX | 1 |
| Baka-Ostrowska, M; Bolong, D; Bosman, B; Dahler, E; Davies, LN; Franco, I; Hoebeke, P; Newgreen, D; Snijder, R; Stroosma, O; Vande Walle, J; Verheggen, F | 1 |
| Aschenbrenner, DS | 1 |
| Krivoborodov, GG; Tur, EI | 1 |
| Blok, BF; Scheepe, JR; Tijnagel, MJ | 1 |
| Baltogiannis, D; Dimitriadis, F; Filiponi, M; Giannakis, J; Sofikitis, N; Takenaka, A; Tsounapi, P; Zachariou, A | 1 |
| Chen, G; Li, Y; Liao, L | 1 |
| Agarwal, M; Amarenco, G; Compion, G; De Ridder, D; Del Popolo, G; Sutory, M; Tretter, R; Zachoval, R | 1 |
| Bolduc, S; Hamel, M; Lamontagne, P; Lebel, S; Moore, K; Nadeau, G | 1 |
| Bosch, JL; Chilman-Blair, K | 1 |
| Hayashi, A; Noguchi, Y; Ohtake, A; Okutsu, H; Sasamata, M; Sato, S; Suzuki, M; Ukai, M; Yoshino, T; Yuyama, H | 1 |
| Krivoborodov, GG; Mazo, EB | 1 |
| Brubaker, L; Chapple, C; Coyne, KS; Kopp, Z | 1 |
5 review(s) available for solifenacin succinate and Urinary Bladder, Neurogenic
| Article | Year |
|---|---|
Efficacy, according to urodynamics, of OnabotulinumtoxinA compared with antimuscarinic drugs, for neurogenic detrusor overactivity: a systematic review and network meta-analysis.
Topics: Bayes Theorem; Botulinum Toxins, Type A; Humans; Muscarinic Antagonists; Network Meta-Analysis; Solifenacin Succinate; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive; Urodynamics | 2022 |
[Comprehensive pharmacologic management of overactive bladder].
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Drug Combinations; Humans; Muscarinic Antagonists; Randomized Controlled Trials as Topic; Solifenacin Succinate; Sulfonamides; Tamsulosin; Thiazoles; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive | 2017 |
Solifenacin: treatment of overactive bladder.
Topics: Animals; Clinical Trials, Phase III as Topic; Drug Evaluation, Preclinical; Humans; Muscarinic Antagonists; Quinuclidines; Receptor, Muscarinic M3; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Neurogenic | 2004 |
[Neurological aspect of the hyperactive urinary bladder syndrome].
Topics: Benzilates; Brain; Brain Diseases; Cerebrovascular Circulation; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Parkinson Disease; Positron-Emission Tomography; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Neurogenic | 2005 |
Patient-reported outcomes in overactive bladder: importance for determining clinical effectiveness of treatment.
Topics: Benzhydryl Compounds; Clinical Trials as Topic; Cresols; Health Status; Humans; Mandelic Acids; Muscarinic Antagonists; Patient Compliance; Patient Satisfaction; Phenylpropanolamine; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Incontinence, Stress | 2006 |
4 trial(s) available for solifenacin succinate and Urinary Bladder, Neurogenic
| Article | Year |
|---|---|
Long-term efficacy and safety of solifenacin in pediatric patients aged 6 months to 18 years with neurogenic detrusor overactivity: results from two phase 3 prospective open-label studies.
Topics: Adult; Child; Humans; Muscarinic Antagonists; Prospective Studies; Solifenacin Succinate; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive; Urinary Incontinence | 2020 |
The possible role of percutaneous tibial nerve stimulation using adhesive skin surface electrodes in patients with neurogenic detrusor overactivity secondary to spinal cord injury.
Topics: Adult; Cervical Vertebrae; Electrodes; Female; Humans; Lumbar Vertebrae; Male; Muscarinic Antagonists; Quality of Life; Solifenacin Succinate; Spinal Cord Injuries; Surveys and Questionnaires; Thoracic Vertebrae; Tibial Nerve; Transcutaneous Electric Nerve Stimulation; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Incontinence | 2015 |
Solifenacin is effective and well tolerated in patients with neurogenic detrusor overactivity: Results from the double-blind, randomized, active- and placebo-controlled SONIC urodynamic study.
Topics: Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Quality of Life; Solifenacin Succinate; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive; Urodynamics; Urological Agents; Young Adult | 2017 |
Prospective open label study of solifenacin for overactive bladder in children.
Topics: Child; Female; Humans; Male; Muscarinic Antagonists; Prospective Studies; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive; Urinary Incontinence | 2010 |
4 other study(ies) available for solifenacin succinate and Urinary Bladder, Neurogenic
| Article | Year |
|---|---|
New Indication for Solifenacin.
Topics: Administration, Oral; Humans; Hydrogen-Ion Concentration; Solifenacin Succinate; Suspensions; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive; Urodynamics; Urological Agents | 2020 |
Real life persistence rate with antimuscarinic treatment in patients with idiopathic or neurogenic overactive bladder: a prospective cohort study with solifenacin.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Male; Medication Adherence; Middle Aged; Muscarinic Antagonists; Prospective Studies; Solifenacin Succinate; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive; Young Adult | 2017 |
Effective treatment of neurogenic detrusor overactivity in multiple sclerosis patients using desmopressin and mirabegron.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Adult; Antidiuretic Agents; Deamino Arginine Vasopressin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscarinic Antagonists; Retreatment; Solifenacin Succinate; Thiazoles; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive; Urinary Incontinence; Urination | 2017 |
Effects of solifenacin succinate (YM905) on detrusor overactivity in conscious cerebral infarcted rats.
Topics: Animals; Benzhydryl Compounds; Benzilates; Cresols; Infarction, Middle Cerebral Artery; Male; Muscarinic Antagonists; Muscle, Smooth; Phenylpropanolamine; Quinuclidines; Rats; Rats, Sprague-Dawley; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder, Neurogenic | 2005 |